Skip to Content
Opening Bell

Side by Side

Compare

Read two to four stocks on the same scale — return, valuation and volatility in one table.

Selected5Y Return
  • AKROAkero Therapeutics Inc+ 118.34%
A single series is normalized to its own start, so it says nothing beyond one line leaving zero.

Period Return

Each series is converted to a percentage of its own starting point, so all of them begin at zero. What is compared is the return over the period, not price levels.

AKRO+ 118.3%Tap or hover the chart for values along the way
MetricAKRO
Return
Last Price54.70
Daily Change
Period ReturnPast 5 Years
+ 118.34%
Valuation
Market Cap$4.50 B
P/E Ratio
Dividend Yield
Net MarginTrailing 12M
Risk
Beta0.90
52-Week Range41.77 — $54.83

Company

  • AKROBiotechnology

CacheUpdated 03:54May Be Out Of Date

To Understand This